venBio Global Strategic Fund III, L.P.

2.9

2.9

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Artiva Biotherapeutics Inc (ARTV)

Transaction date 22 Jul 2024

Purchase

Price

288.63

Quantity 80,415 -44.9%

Value US$3,217,869

Comments Filing

Elevation Oncology Inc (ELEV)

Transaction date 25 May 2022

Sale

Price

260.92

Quantity 48,056 -45.5%

Value US$3,794,147

Comments Filing

Ventyx Biosciences Inc (VTYX)

Transaction date 25 Oct 2021

Purchase

Price

150.17

Quantity 74,968 +20.6%

Value US$3,745,442

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-07-22	2024-07-22	Artiva Biotherapeutics Inc (ARTV)	B Purchase	80,415 -44.9% 288.63 US$3,217,869	80,415 -44.9%	288.63	US$3,217,869
2022-05-27	2022-05-25	Elevation Oncology Inc (ELEV)	S Sale	48,056 -45.5% 260.92 US$3,794,147	48,056 -45.5%	260.92	US$3,794,147
2021-10-25	2021-10-25	Ventyx Biosciences Inc (VTYX)	B Purchase	74,968 +20.6% 150.17 US$3,745,442	74,968 +20.6%	150.17	US$3,745,442